Proxygen
PrivateLast Round
Strategic
Apr 5, 2023
Total Funding Raised
$250,000
Company Overview
Proxygen is a biotechnology company developing a new class of therapeutics based on induced proximity to address high-value targets in oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proxygen Comparables
Compare Proxygen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomorph | 89% | |
| Degron Therapeutics | 88% | |
| Plexium | 88% |
Proxygen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 5, 2023 | ||||
| Strategic | Jun 2, 2022 | ||||
| Strategic | Dec 7, 2020 | ||||
| Grant | Jul 31, 2020 |
Key People
Founding team and executive leadership
Proxygen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Grant, Strategic |
| Wlanholding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 49% MoM.
- Aug 8, 2023
Grew 30% QoQ, from 23 to 30 employees.
Proxygen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Proxygen's valuation, stock price, and market status.
Is Proxygen a public or private company?
Proxygen is a private company.
What is the current stock price of Proxygen?
Proxygen is a private company with no public stock price. No recent secondary market data is available.
How much is Proxygen worth (valuation)?
Valuation information for Proxygen is not publicly available.
Can I buy Proxygen stock?
Proxygen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Proxygen's last funding round?
Proxygen's most recent funding round was Strategic on April 5, 2023.
Who are the main investors in Proxygen?
Key investors in Proxygen include Boehringer Ingelheim, Wlanholding.
Will Proxygen IPO soon?
No public IPO plans have been announced for Proxygen.
How can I track Proxygen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proxygen's secondary market activity and sign up for updates.